Takaisin Tulosta

Biomarkkerit ja atrofinen gastriitti

Lisätietoa aiheesta
alkuperäinen kirjoittaja: Anna-Liisa Karvonen; tarkastettu 10.4.2019


  1. Väänänen H, Vauhkonen M, Helske T ym. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91 «PMID: 12867799»PubMed
  2. Storskrubb T, Aro P, Ronkainen J ym. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008;43:1448-55 «PMID: 18663663»PubMed
  3. Lombardo L, Leto R, Molinaro G ym. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med 2010;48:1327-32 «PMID: 20604730»PubMed
  4. Germaná B, Di Mario F, Cavallaro LG ym. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 2005;37:501-8 «PMID: 15975537»PubMed
  5. Daugule I, Sudraba A, Chiu HM ym. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol 2011;23:302-7 «PMID: 21389862»PubMed
  6. van Marrewijk CJ, van Oijen MG, Paloheimo LI ym. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Aliment Pharmacol Ther 2009;30:82-9 «PMID: 19309389»PubMed
  7. Peitz U, Wex T, Vieth M ym. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. J Gastroenterol Hepatol 2011;26:82-9 «PMID: 21175799»PubMed
  8. Agréus L, Kuipers EJ, Kupcinskas L ym. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136-47 «PMID: 22242613»PubMed